These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 20166945)
1. The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs. Glennon RA; Siripurapu U; Roth BL; Kolanos R; Bondarev ML; Sikazwe D; Lee M; Dukat M Curr Top Med Chem; 2010; 10(5):579-95. PubMed ID: 20166945 [TBL] [Abstract][Full Text] [Related]
11. Medicinal chemistry of 5-HT5A receptor ligands: a receptor subtype with unique therapeutical potential. Volk B; Nagy BJ; Vas S; Kostyalik D; Simig G; Bagdy G Curr Top Med Chem; 2010; 10(5):554-78. PubMed ID: 20166946 [TBL] [Abstract][Full Text] [Related]
12. 1-(Arylsulfonyl)-2,3-dihydro-1H-quinolin-4-one derivatives as 5-HT(6) serotonin receptor ligands. Park CM; Choi JI; Choi JH; Kim SY; Park WK; Seong CM Bioorg Med Chem Lett; 2011 Jan; 21(2):698-703. PubMed ID: 21190848 [TBL] [Abstract][Full Text] [Related]
13. 1,2,3,4-tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands. Chang-Fong J; Rangisetty JB; Dukat M; Setola V; Raffay T; Roth B; Glennon RA Bioorg Med Chem Lett; 2004 Apr; 14(8):1961-4. PubMed ID: 15050637 [TBL] [Abstract][Full Text] [Related]
14. N-arylsulfonyl-2-vinyltryptamines as new 5-HT6 serotonin receptor ligands. Raoul M; Patigny D; Fabis F; Dauphin F; Rault S; Sapi J; Laronze JY J Enzyme Inhib Med Chem; 2006 Jun; 21(3):251-60. PubMed ID: 16918072 [TBL] [Abstract][Full Text] [Related]
15. Whole spectrum analysis of ligand efficacy at constitutively active human wild-type and S267K 5-HT6 receptors in HEK-293F cells. Romero G; Pujol M; Pérez P; Buschmann H; Pauwels PJ J Pharmacol Toxicol Methods; 2007; 55(2):144-50. PubMed ID: 16769227 [TBL] [Abstract][Full Text] [Related]
16. Memories are made of this (perhaps): a review of serotonin 5-HT(6) receptor ligands and their biological functions. Russell MG; Dias R Curr Top Med Chem; 2002 Jun; 2(6):643-54. PubMed ID: 12052198 [TBL] [Abstract][Full Text] [Related]
17. Optimization of N'-(arylsulfonyl)pyrazoline-1-carboxamidines by exploiting a novel interaction site in the 5-HT6 antagonistic binding pocket. van Loevezijn A; Venhorst J; Iwema Bakker WI; Lange JHM; de Looff W; Henzen R; de Vries J; van de Woestijne RP; den Hartog AP; Verhoog S; van der Neut MAW; de Bruin NMWJ; Kruse CG Bioorg Med Chem Lett; 2016 Mar; 26(6):1605-1611. PubMed ID: 26876931 [TBL] [Abstract][Full Text] [Related]
18. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins. Kim HJ; Yun HM; Kim T; Nam G; Roh EJ; Kostenis E; Choo HY; Pae AN; Rhim H Comb Chem High Throughput Screen; 2008 May; 11(4):316-24. PubMed ID: 18473741 [TBL] [Abstract][Full Text] [Related]
19. Pharmacophore models for metabotropic 5-HT receptor ligands. Bojarski AJ Curr Top Med Chem; 2006; 6(18):2005-26. PubMed ID: 17017971 [TBL] [Abstract][Full Text] [Related]
20. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands. Westkaemper RB; Glennon RA Curr Top Med Chem; 2002 Jun; 2(6):575-98. PubMed ID: 12052195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]